Advertisement

Biological Trace Element Research

, Volume 150, Issue 1–3, pp 467–476 | Cite as

Growth Control in Colon Epithelial Cells: Gadolinium Enhances Calcium-Mediated Growth Regulation

  • Durga Attili
  • Brian Jenkins
  • Muhammad Nadeem Aslam
  • Michael K. Dame
  • James VaraniEmail author
Article

Abstract

Gadolinium, a member of the lanthanoid family of transition metals, interacts with calcium-binding sites on proteins and other biological molecules. The overall goal of the present investigation was to determine if gadolinium could enhance calcium-induced epithelial cell growth inhibition in the colon. Gadolinium at concentrations as low as 1–5 μM combined with calcium inhibits proliferation of human colonic epithelial cells more effectively than calcium alone. Gadolinium had no detectable effect on calcium-induced differentiation in the same cells based on change in cell morphology, induction of E-cadherin synthesis, and translocation of E-cadherin from the cytosol to the cell surface. When the colon epithelial cells were treated with gadolinium and then exposed to increased calcium concentrations, movement of extracellular calcium into the cell was suppressed. In contrast, gadolinium treatment had no effect on ionomycin-induced release of stored intracellular calcium into the cytoplasm. Whether these in vitro observations can be translated into an approach for reducing abnormal proliferation in the colonic mucosa (including polyp formation) is not known. These results do, however, provide an explanation for our recent findings that a multi-mineral supplement containing all of the naturally occurring lanthanoid metals including gadolinium are more effective than calcium alone in preventing colon polyp formation in mice on a high-fat diet.

Keywords

Calcium Gadolinium Colon Differentiation Cytotoxicity 

Notes

Acknowledgments

This study was supported in part by grant CA140760 from the National Institutes of Health, Bethesda, MD and by grant 11–0577 from the Association for International Cancer Research, St. Andrews, Fife, Scotland.

References

  1. 1.
    Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR (1993) Calcium, vitamin D, dairy foods intake to incidence of colon cancer among older women. The Iowa women’s health study. Am J Epidemiol 137:1302–1317PubMedGoogle Scholar
  2. 2.
    Kampman E, Giovannucci E, van ‘t Veer P, Rimm E, Stampfer MJ, Colditz GA, Kok FJ, Willett WC (1994) Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol 139:16–29PubMedGoogle Scholar
  3. 3.
    Kampman E, Slattery ML, Caan B, Potter JD (2000) Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 11:459–466PubMedCrossRefGoogle Scholar
  4. 4.
    McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A, Carolyn J, Calle EE, Willett WC, Thun MJ (2003) Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 14:1–12PubMedCrossRefGoogle Scholar
  5. 5.
    Flood A, Peters U, Chatterjee N, Lacey JV Jr, Schairer C, Schatzkin A (2005) Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women. Cancer Epidemiol Biomarkers Prev 14:126–132PubMedGoogle Scholar
  6. 6.
    Wakai K, Hirose K, Matsuo K, Ito H, Kuriki K, Suzuki T, Kato T, Hirai T, Kanemitsu Y, Tajima K (2006) Dietary risk factors for colon and rectal cancers: a comparative case–control study. J Epidemiol 16:125–135PubMedCrossRefGoogle Scholar
  7. 7.
    Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340:101–107PubMedCrossRefGoogle Scholar
  8. 8.
    Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, Heber D (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95:1765–1771PubMedCrossRefGoogle Scholar
  9. 9.
    Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, Shinozaki H (2001) A Western-style diet induces benign and malignant neoplasms in the colon of normal C57BI/6 mice. Carcinogenesis 22:1871–1875PubMedCrossRefGoogle Scholar
  10. 10.
    Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M (2009) Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57BI/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 30:88–92PubMedCrossRefGoogle Scholar
  11. 11.
    Behrens J, Vakaet L, Friis R, Winterchger E, van Roy F, Mareel MM, Birchmeier W (1992) Loss of epithelial differentiation and gain of invasiveness correlates with tryrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120:757–766CrossRefGoogle Scholar
  12. 12.
    Tu CL, Oda Y, Bikle DD (1999) Effects of a calcium receptor activator on the cellular response to calcium in human keratinocytes. J Investig Dermatol 113:340–345PubMedCrossRefGoogle Scholar
  13. 13.
    Tu CL, Oda Y, Komuves L, Bikle DD (2004) The role of the calcium-sensing receptor in epidermal differentiation. Cell Calcium 35:265–273PubMedCrossRefGoogle Scholar
  14. 14.
    Chakrabarty S, Radjendirane V, Appelman H, Varani J (2003) Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-catenin/TCF activation. Cancer Res 63:67–71PubMedGoogle Scholar
  15. 15.
    Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H, Varani J (2005) Calcium sensing receptor in human colon carcinoma: Interaction with Ca2+ and 1,25-dihydroxyvitamin D3. Cancer Res 65:493–498PubMedGoogle Scholar
  16. 16.
    Brembeck FH, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, Birchmeier W (2004) Essential role of BCL9-2 in the switch between β-catenin’s adhesive function and transcriptional functions. Gene Dev 18:2225–2230PubMedCrossRefGoogle Scholar
  17. 17.
    Bhagavathula N, Hanosh AW, Nerusu KC, Appelman H, Chakrabarty S, Varani J (2007) Regulation of E-cadherin and β-catenin by Ca2+ in colon carcinoma is dependent on calcium-sensing receptor expression and function. Int J Cancer 121:1455–1462PubMedCrossRefGoogle Scholar
  18. 18.
    Bostick RM, Goodman M, Sidelnikov E (2009) Calcium and vitamin D. In: Potter JD, Lindor NM (eds) Genetics of colorectal cancer. Springer, New York, pp 273–294Google Scholar
  19. 19.
    Aslam MN, Bergin I, Naik M, Hampton A, Rehman M, Dame MK, Rush H, Varani J (2012) A multi-mineral natural product from red marine algae reduces colon polyp formation in C57BL/6 mice. Nutr Cancer 64(7). doi: 10.1080/01635581.2012.713160
  20. 20.
    Evans CH (ed) (1990) Biochemistry of the lanthanides. In: Biochemistry of the elements. Plenum, New YorkGoogle Scholar
  21. 21.
    Gschneidner KA Jr, Eyring L (eds) (2000) Handbook on the physics and chemistry of rare earths. Elsevier, AmsterdamGoogle Scholar
  22. 22.
    Lansman JB (1990) Blockade of current through single calcium channels by trivalent lanthanide cations. Effect of ionic radius on the rates of ion entry and exit. J Gen Physiol 95(4):679–696PubMedCrossRefGoogle Scholar
  23. 23.
    Huang Y, Zhou Y, Castiblanco A, Yang W, Brown EM, Yang JJ (2009) Multiple Ca(2+)-binding sites in the extracellular domain of the Ca(2+)-sensing receptor corresponding to cooperative Ca(2+) response. Biochemistry 48(2):388–398PubMedCrossRefGoogle Scholar
  24. 24.
    Palasz A, Czekaj P (2000) Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim Pol 47(4):1107–1114PubMedGoogle Scholar
  25. 25.
    Pidcock E, Moore GR (2001) Structural characteristics of protein binding sites for calcium and lanthanide ions. J Biol Inorg Chem 6(5–6):479–489PubMedCrossRefGoogle Scholar
  26. 26.
    McLarnon SJ, Riccardi D (2002) Physiological and pharmacological agonists of the extracellular Ca2+-sensing receptor. Eur J Pharmacol 447(2–3):271–278PubMedCrossRefGoogle Scholar
  27. 27.
    Riccardi D, Maldonado-Perez D (2005) The calcium-sensing receptor as a nutrient sensor. Biochem Soc Trans 33(Pt 1):316–320PubMedGoogle Scholar
  28. 28.
    Ward DT, Brown EM, Harris HW (1998) Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J Biol Chem 273(23):14476–14483PubMedCrossRefGoogle Scholar
  29. 29.
    Jenkins W, Perone P, Walker K, Bhagavathula N, Aslam MN, Dasilva M, Dame MK, Varani J (2011) Fibroblast response to lanthanoid metal ion stimulation: potential contribution to fibrotic tissue injury. Biol Trace Elem Res 144:621–635PubMedCrossRefGoogle Scholar
  30. 30.
    Vandenberghe PA, Ceuppens JL (1990) Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods 127:197–205PubMedCrossRefGoogle Scholar
  31. 31.
    Loughrey CM, MacEachern KE, Cooper J, Smith GL (2003) Measurement of the dissociation constant of flou-3 for Ca2+ in isolated rabbit cardiomyocytes using Ca2+ wave characteristics. Cell Calcium 34:1–9PubMedCrossRefGoogle Scholar
  32. 32.
    Bleavins K, Perone P, Naik M, Rehman M, Aslam MN, Dame MK, Meshinchi S, Bhagavathula N, Varani J (2012) Stimulation of fibroblast proliferation by insoluble gadolinium salts. Biol Trace Element Res 145:257–267CrossRefGoogle Scholar
  33. 33.
    Mason RP (1999) Calcium channel blockers, apoptosis and cancer: is there a biologic relationship? J Am Coll Cardiol 34:1857–1866PubMedCrossRefGoogle Scholar
  34. 34.
    Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552–565PubMedCrossRefGoogle Scholar
  35. 35.
    Liu G, Hu X, Premkumar L, Chakrabarty S (2011) Nifedipine synergizes with calcium in activating the calcium sensing receptor, suppressing the expression of thymidylate synthase and survivin and promoting sensitivity to fluorouracil in human colon carcinoma cells. Mol Carcinog 50:922–930PubMedCrossRefGoogle Scholar
  36. 36.
    Caldwell RA, Clemo HF, Baumgarten CM (1998) Using gadolinium to identify stretch-activated channels: technical considerations. Am J Physiol 275(2 Pt 1):C619–C621PubMedGoogle Scholar
  37. 37.
    Estacion M, Mordan LJ (1993) Competence induction by PDGF requires sustained calcium influx by a mechanism distinct from storage-dependent calcium influx. Cell Calcium 14(6):439–454PubMedCrossRefGoogle Scholar
  38. 38.
    Edward M, Quinn JA, Mukherjee S et al (2008) Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214(5):584–593PubMedCrossRefGoogle Scholar
  39. 39.
    Varani J, DaSilva M, Warner RL et al (2009) Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Investig Radiol 44(2):74–81CrossRefGoogle Scholar
  40. 40.
    Edward M, Quinn JA, Burden AD et al (2010) Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Radiology 256(3):735–743PubMedCrossRefGoogle Scholar
  41. 41.
    Wiesinger B, Kehlbach R, Bebin J et al (2010) Effects of MRI contrast agents on human embryonic lung fibroblasts. Investig Radiol 45(9):513–519CrossRefGoogle Scholar
  42. 42.
    Bhagavathula N, Dame MK, Dasilva M et al (2010) Fibroblast response to gadolinium: role for platelet-derived growth factor receptor. Investig Radiol 45(12):769–777CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Durga Attili
    • 1
  • Brian Jenkins
    • 1
  • Muhammad Nadeem Aslam
    • 1
  • Michael K. Dame
    • 1
  • James Varani
    • 1
    Email author
  1. 1.Department of PathologyUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations